Back
Kymera Therapeutics Vs. Vir Biotechnology Industry Stock Comparison
Buy
75
KYMR
Kymera Therapeutics
Last Price:
48.67
Seasonality Move:
52.76%
Sell
19
VIR
Vir Biotechnology
Last Price:
9.00
Seasonality Move:
40.05%
Buy
75
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $50.05. The Score for KYMR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Vir Biotechnology (VIR)
is a Sell
Is Vir Biotechnology a Buy, Sell or Hold?
- The current Vir Biotechnology [VIR] share price is $9.25. The Score for VIR is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- VIR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $50.05
The current trend is moderately bullish and KYMR is experiencing slight selling pressure.
VIR Stock Price Chart
What is Vir Biotechnology's stock price today?
-
The Vir Biotechnology share price today is $9.25
The current trend is moderately bullish and VIR is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.03 | Buy |
| Relative Strength Index (14 RSI): | 57.39 | Buy |
| Chaikin Money Flow: | -137989 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.13 - 49.75) | Buy |
| Bollinger Bands (100): | (38.59 - 49.75) | Buy |
VIR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 59.65 | Buy |
| Chaikin Money Flow: | -740219 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.24 - 9.2) | Buy |
| Bollinger Bands (100): | (7.59 - 9.49) | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.18 | Buy |
| 20-day SMA: | 48.27 | Buy |
| 50-day SMA: | 47.21 | Buy |
| 200-day SMA: | 40.45 | Buy |
| 8-day EMA: | 49.65 | Buy |
| 20-day EMA: | 48.44 | Buy |
| 50-day EMA: | 46.96 | Buy |
| 200-day EMA: | 40.14 | Buy |
VIR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.62 | Sell |
| 20-day SMA: | 8.41 | Buy |
| 50-day SMA: | 7.95 | Buy |
| 200-day SMA: | 9.22 | Buy |
| 8-day EMA: | 9.34 | Sell |
| 20-day EMA: | 8.71 | Buy |
| 50-day EMA: | 8.35 | Buy |
| 200-day EMA: | 9.54 | Sell |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.50 per share.
Vir Biotechnology Earnings Growth & VIR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and an increase next year of $0.10 per share.
Kymera Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vir Biotechnology Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||